TY - JOUR
T1 - Perceptions about corporate positioning on controversial sociopolitical issues
T2 - examining big pharma engagement with patient advocacy
AU - Müller, Naíde
N1 - Funding Information:
This research was financially supported by the Portuguese National Funding Agency for Science, Research and Technology, Foundation for Science and Technology (FCT), PhD Grant No. SFRH/BD/144467/2019.
Funding Information:
GAT receives formal financial support from seven companies in the pharmaceutical industry: Abbvie; Alere/Abbott; AstraZeneca; Farmoz/Grupo Tecnimede; Gilead; Janssen; MSD. During the period of ethnographic immersion, it was possible to verify that:
Funding Information:
This research was financially supported by the Portuguese National Funding Agency for Science , Research and Technology, Foundation for Science and Technology (FCT), PhD Grant No. SFRH/BD/144467/2019 .
Publisher Copyright:
© 2022 The Authors
PY - 2022/12
Y1 - 2022/12
N2 - There is evidence of the perception that business is not doing enough to address societal problems. As a result, some companies have used corporate activism to demonstrate their support for causes and position themselves on specific issues. These positioning efforts are at the heart of public relations activities with the potential to create changes in socially constructed realities. This research examines the relationships between pharmaceutical companies and patient advocacy, focusing on analyzing companies' engagement in controversial sociopolitical issues. An ethnographic study was conducted for six months — including document analysis, 33 interviews, and participant observation — with a Portuguese patient advocacy group. The CSR domains on thhe websites of seven pharmaceutical companies were also analyzed. Findings suggest that despite financial and technical support, the pharma companies do not publicly engage with the patient advocacy group's main struggles for human rights. Changes in the companies' positioning may improve the perceptions of these stakeholders about their engagement with causes and encourage more robust partnerships toward social change.
AB - There is evidence of the perception that business is not doing enough to address societal problems. As a result, some companies have used corporate activism to demonstrate their support for causes and position themselves on specific issues. These positioning efforts are at the heart of public relations activities with the potential to create changes in socially constructed realities. This research examines the relationships between pharmaceutical companies and patient advocacy, focusing on analyzing companies' engagement in controversial sociopolitical issues. An ethnographic study was conducted for six months — including document analysis, 33 interviews, and participant observation — with a Portuguese patient advocacy group. The CSR domains on thhe websites of seven pharmaceutical companies were also analyzed. Findings suggest that despite financial and technical support, the pharma companies do not publicly engage with the patient advocacy group's main struggles for human rights. Changes in the companies' positioning may improve the perceptions of these stakeholders about their engagement with causes and encourage more robust partnerships toward social change.
KW - Activism
KW - Public relations
KW - Social change
KW - Corporate social responsibility
KW - Corporate political advocacy
UR - http://www.scopus.com/inward/record.url?scp=85140804542&partnerID=8YFLogxK
U2 - 10.1016/j.pubrev.2022.102261
DO - 10.1016/j.pubrev.2022.102261
M3 - Article
SN - 0363-8111
VL - 48
JO - Public Relations Review
JF - Public Relations Review
IS - 5
M1 - 102261
ER -